WAM
LXRX icon

World Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

World Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,570
Closed -$15K – 1440
2014
Q3 		$15K Hold
1,570
– – ﹤0.01% 1485
2014
Q2 		$18K Sell
1,570
-317
-17% -$3.4K ﹤0.01% 1529
2014
Q1 		$23K Buy
1,887
+96
+5% +$1.23K ﹤0.01% 1517
2013
Q4 		$23K Sell
1,791
-783
-30% -$12.5K ﹤0.01% 1554
2013
Q3 		$43K Sell
2,574
-3,638
-59% -$61K ﹤0.01% 1688
2013
Q2 		$94K Buy
+6,212
New +$94.4K ﹤0.01% 1694

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $677M AUM 57.21% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return